Hye-Ryun Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hye-Ryun Kang has a total of 956 co-authors. Here are the top co-authors by number of shared publications:
Sang-Heon Cho
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
32 shared publicationsJae-Woo Jung
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
29 shared publications- Dong Yoon Kang
Department of Preventive Medicine, Ulsan University Hospital, University of Ulsan College of Medicine , Ulsan
19 shared publications - Sang-Heon Cho
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
19 shared publications Suh-Young Lee
Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea
18 shared publicationsKyung-Up Min
Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
16 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 41 (6) , 1141-1151
Clinical features of moderate-to-severe antibiotic allergy in Korea: analysis from the drug allergy safety information sharing system database
Background/Aims: Antibiotics are major causes of drug allergy. Sharing standardized information on culprit agents is essential to prevent recurrent drug allergy. In 2024, the Ministry of Health and Welfare established the Drug Allergy Safety Information Sharing System (DASI), integrated with the Personal Health Record (PHR). We analyzed the epidemiology, culprit antibiotics, clinical manifestations, and diagnostic practices of antibiotic allergy in Korea using DASI data.Methods: We retrospectively reviewed 807 cases of moderate-to-severe antibiotic allergy from eight tertiary hospitals. Clinical features were assessed according to reaction type, severity, MedDRA system organ class, culprit antibiotics, and diagnostic methods.Results: Of 807 cases, the most common manifestations were cutaneous (77.1%), immune (35.2%), and respiratory (23.7%) symptoms. Most cases were caused by β-lactams, particularly second-generation cephalosporins (43.1%). Regarding single agent, cefaclor was the leading culprit (36.7%) and showed significant associations with immediate (odds ratio [OR] 13.88, 95% confidence interval [CI] 7.37–29.75) and severe reactions (OR 3.39, 95% CI 2.52–4.59). Immediate reactions frequently involved multiple organs, while 95.7% of delayed reactions involved the skin. β-lactams were the leading culprits of both immediate and delayed reactions, while sulfamethoxazole/trimethoprim, tetracyclines, and glycopeptides were identified as the major culprits of delayed reactions. Diagnosis relied mainly on clinical assessment (45.4%), while confirmatory drug provocation testing was performed in only 11.8%.Conclusions: Immediate antibiotic allergy in Korea was mainly caused by β-lactams, with cefaclor identified as the leading culprit for severe reactions. Delayed reactions were characterized by a relatively greater contribution of non-β-lactam antibiotics than immediate reactions.
- 1 November 2026
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 41 (6) , 1141-1151
Open AccessClinical features of moderate-to-severe antibiotic allergy in Korea: analysis from the drug allergy safety information sharing system database
Background/Aims: Antibiotics are major causes of drug allergy. Sharing standardized information on culprit agents is essential to prevent recurrent drug allergy. In 2024, the Ministry of Health and Welfare established the Drug Allergy Safety Information Sharing System (DASI), integrated with the Personal Health Record (PHR). We analyzed the epidemiology, culprit antibiotics, clinical manifestations, and diagnostic practices of antibiotic allergy in Korea using DASI data.Methods: We retrospectively reviewed 807 cases of moderate-to-severe antibiotic allergy from eight tertiary hospitals. Clinical features were assessed according to reaction type, severity, MedDRA system organ class, culprit antibiotics, and diagnostic methods.Results: Of 807 cases, the most common manifestations were cutaneous (77.1%), immune (35.2%), and respiratory (23.7%) symptoms. Most cases were caused by β-lactams, particularly second-generation cephalosporins (43.1%). Regarding single agent, cefaclor was the leading culprit (36.7%) and showed significant associations with immediate (odds ratio [OR] 13.88, 95% confidence interval [CI] 7.37–29.75) and severe reactions (OR 3.39, 95% CI 2.52–4.59). Immediate reactions frequently involved multiple organs, while 95.7% of delayed reactions involved the skin. β-lactams were the leading culprits of both immediate and delayed reactions, while sulfamethoxazole/trimethoprim, tetracyclines, and glycopeptides were identified as the major culprits of delayed reactions. Diagnosis relied mainly on clinical assessment (45.4%), while confirmatory drug provocation testing was performed in only 11.8%.Conclusions: Immediate antibiotic allergy in Korea was mainly caused by β-lactams, with cefaclor identified as the leading culprit for severe reactions. Delayed reactions were characterized by a relatively greater contribution of non-β-lactam antibiotics than immediate reactions.
- Open Access
- 22 May 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 319, 120224
Air pollutants elicit type 3 immune response in asthma through Ly6C+ monocyte-derived macrophages
- 22 May 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 319, 120224
Open AccessAir pollutants elicit type 3 immune response in asthma through Ly6C+ monocyte-derived macrophages
- Open Access
- 13 May 2026
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 16 (5) , 253-259
The clinical course of nasal polyps in relation with histological and radiological findings
Background: Nasal polyps (NPs) show distinct characteristics in histologic features with different inflammatory cells and stromal changes, but their clinical implications remain poorly understood. Objective: To determine the associations between NP histology, clinical characteristics, radiologic disease burden on osteomeatal unit computed tomography (OMU-CT) findings, and postoperative recurrence. Methods: We retrospectively reviewed 219 patients who underwent nasal polypectomy. NPs were histologically classified by predominant inflammatory cells (eosinophilic vs. lymphoplasmacytic) and stromal features (edematous, glandular, or dense). Clinical variables, preoperative OMU-CT scores, and recurrence rates were analyzed. Results: Overall, 62.6% (137/219) of NPs were eosinophilic. Edematous stroma was the most common stromal subtype (72.6%, 159/219), predominating in eosinophilic NPs (96.3%, 132/137). Patients with eosinophilic NPs showed higher CT severity scores (18.4 ± 0.7 vs. 15.5 ± 1.1; P = 0.021) and a higher prevalence of extended disease (78.3% vs. 60.0%; P = 0.010) than those with lymphoplasmacytic NPs. CT severity score correlated with blood eosinophil counts ( r = 0.17, P = 0.018). Patients with asthma (11.9%) showed higher CT severity scores (22.4 ± 1.4 vs. 16.9 ± 0.6; P = 0.002) and a tendency toward extended disease (92.0% vs. 70.3%; P = 0.052) compared to those without asthma. Among 99 patients with follow-up, recurrence occurred in 16.2%. While recurrence rates did not differ by histologic type, recurrent cases had significantly higher preoperative CT scores than nonrecurrent cases (21.9 vs. 16.9; P = 0.002). Conclusion: Eosinophilic NPs are associated with greater CT disease burden and extent. Peripheral eosinophil counts reflect tissue eosinophilia and correlate with radiologic severity.
- 13 May 2026
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 16 (5) , 253-259
Open AccessThe clinical course of nasal polyps in relation with histological and radiological findings
Background: Nasal polyps (NPs) show distinct characteristics in histologic features with different inflammatory cells and stromal changes, but their clinical implications remain poorly understood. Objective: To determine the associations between NP histology, clinical characteristics, radiologic disease burden on osteomeatal unit computed tomography (OMU-CT) findings, and postoperative recurrence. Methods: We retrospectively reviewed 219 patients who underwent nasal polypectomy. NPs were histologically classified by predominant inflammatory cells (eosinophilic vs. lymphoplasmacytic) and stromal features (edematous, glandular, or dense). Clinical variables, preoperative OMU-CT scores, and recurrence rates were analyzed. Results: Overall, 62.6% (137/219) of NPs were eosinophilic. Edematous stroma was the most common stromal subtype (72.6%, 159/219), predominating in eosinophilic NPs (96.3%, 132/137). Patients with eosinophilic NPs showed higher CT severity scores (18.4 ± 0.7 vs. 15.5 ± 1.1; P = 0.021) and a higher prevalence of extended disease (78.3% vs. 60.0%; P = 0.010) than those with lymphoplasmacytic NPs. CT severity score correlated with blood eosinophil counts ( r = 0.17, P = 0.018). Patients with asthma (11.9%) showed higher CT severity scores (22.4 ± 1.4 vs. 16.9 ± 0.6; P = 0.002) and a tendency toward extended disease (92.0% vs. 70.3%; P = 0.052) compared to those without asthma. Among 99 patients with follow-up, recurrence occurred in 16.2%. While recurrence rates did not differ by histologic type, recurrent cases had significantly higher preoperative CT scores than nonrecurrent cases (21.9 vs. 16.9; P = 0.002). Conclusion: Eosinophilic NPs are associated with greater CT disease burden and extent. Peripheral eosinophil counts reflect tissue eosinophilia and correlate with radiologic severity.
- Open Access
- 8 May 2026
- Published by Korean Cancer Association in Cancer Research and Treatment
Impact of Carboplatin-Free Interval on Hypersensitivity Risks in Solid Tumor Patients with Silent Sensitization
Impact of Carboplatin-Free Interval on Hypersensitivity Risks in Solid Tumor Patients with Silent Sensitization
- 8 May 2026
- Published by Korean Cancer Association in Cancer Research and Treatment
Open AccessImpact of Carboplatin-Free Interval on Hypersensitivity Risks in Solid Tumor Patients with Silent Sensitization
Impact of Carboplatin-Free Interval on Hypersensitivity Risks in Solid Tumor Patients with Silent Sensitization
- 2 March 2026
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 136 (3) , 361
Clarifying the scope of 1-bag rapid desensitization
- 2 March 2026
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 136 (3) , 361
Clarifying the scope of 1-bag rapid desensitization
- Top Cited PapersOpen Access
The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA 2 LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), with the participation of 210 delegates from 107 national and international societies, from 59 countries. The consensus conference was held on December 6th, 2024. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell‐driven disease, defined by a rapid appearance of wheals, angioedema, or both. The lifetime prevalence of acute urticaria is estimated to be approximately 20%. Chronic urticaria, categorized as either chronic spontaneous urticaria or chronic inducible urticaria, is disabling, impairs quality of life, and affects performance at work and school, however, novel therapies are available. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert‐guided and evidence‐based diagnostic and therapeutic approaches for the different subtypes of urticaria.
Top Cited PapersOpen AccessThe International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA 2 LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), with the participation of 210 delegates from 107 national and international societies, from 59 countries. The consensus conference was held on December 6th, 2024. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell‐driven disease, defined by a rapid appearance of wheals, angioedema, or both. The lifetime prevalence of acute urticaria is estimated to be approximately 20%. Chronic urticaria, categorized as either chronic spontaneous urticaria or chronic inducible urticaria, is disabling, impairs quality of life, and affects performance at work and school, however, novel therapies are available. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert‐guided and evidence‐based diagnostic and therapeutic approaches for the different subtypes of urticaria.
- Open Access
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (5) , 776-792
Genome-Wide Risk Assessment and Clinical Prediction of Iodinated Contrast Media–Induced Anaphylaxis
Chung SJ, et al. Allergy Asthma Immunol Res. 2026 Sep;18(5):776-792. https://doi.org/10.4168/aair.2026.18.5.776
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (5) , 776-792
Open AccessGenome-Wide Risk Assessment and Clinical Prediction of Iodinated Contrast Media–Induced Anaphylaxis
Chung SJ, et al. Allergy Asthma Immunol Res. 2026 Sep;18(5):776-792. https://doi.org/10.4168/aair.2026.18.5.776
- Open Access
- 1 January 2026
- Published by XMLink in Immune Network
- Vol. 26 (2) , e17
Cigarette Smoke Induces the Pro-inflammatory Response of Lung Macrophages via Activation of the IL-33/ST2-Dependent Pathway
Kim Y, et al. Immune Netw. 2026 Apr;26(2):e17. https://doi.org/10.4110/in.2026.26.e17
- 1 January 2026
- Published by XMLink in Immune Network
- Vol. 26 (2) , e17
Open AccessCigarette Smoke Induces the Pro-inflammatory Response of Lung Macrophages via Activation of the IL-33/ST2-Dependent Pathway
Kim Y, et al. Immune Netw. 2026 Apr;26(2):e17. https://doi.org/10.4110/in.2026.26.e17
- Open Access
- 1 January 2026
- Published by XMLink in Allergy Asthma & Respiratory Disease
- Vol. 14 (1) , 4-13
Clinical management of hypersensitivity reactions to antituberculosis drugs
박세진, et al. Allergy Asthma Respir Dis. 2026 Jan;14(1):4-13. https://doi.org/10.4168/aard.2026.14.1.4
- 1 January 2026
- Published by XMLink in Allergy Asthma & Respiratory Disease
- Vol. 14 (1) , 4-13
Open AccessClinical management of hypersensitivity reactions to antituberculosis drugs
박세진, et al. Allergy Asthma Respir Dis. 2026 Jan;14(1):4-13. https://doi.org/10.4168/aard.2026.14.1.4